Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2011-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10096-010-1122-9PMID 21140187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drug resistance in malaria.

  2011cited by this paper
• Glial activation and matrix metalloproteinase release in cerebral malaria

  2011cited by this paper
• Plasmodium falciparum Adhesion on Human Brain Microvascular Endothelial Cells Involves Transmigration-Like Cup Formation and Induces Opening of Intercellular Junctions

  2010cited by this paper
• Parasite-Derived Plasma Microparticles Contribute Significantly to Malaria Infection-Induced Inflammation through Potent Macrophage Stimulation

  2010cited by this paper
• Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases.

  2010cited by this paper
• Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome

  2010cited by this paper
• Artemisone effective against murine cerebral malaria

  2010cited by this paper
• Transporters as mediators of drug resistance in Plasmodium falciparum.

  2010cited by this paper
• Serum levels of S100B and NSE proteins in Alzheimer's disease patients

  2010cited by this paper
• The role of platelets in the pathogenesis of cerebral malaria

  2010cited by this paper
• Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine.

  2010cited by this paper
• Curcumin improves sclerosing cholangitis in Mdr2−/− mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation

  2010cited by this paper
• Activation of peroxisome proliferator-activated receptor gamma in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema.

  2010cited by this paper
• Targeting Plasmodium falciparum purine salvage enzymes: a look at structure-based drug development.

  2010cited by this paper
• Nanotechnology applied to the treatment of malaria.

  2010cited by this paper
• The PPAR-γ Agonist, Darglitazone, Restores Acute Inflammatory Responses to Cerebral Hypoxia–Ischemia in the Diabetic ob/ob Mouse

  2010cited by this paper
• Immune-Mediated Mechanisms of Parasite Tissue Sequestration during Experimental Cerebral Malaria

  2010cited by this paper
• Modulation of cerebral malaria by fasudil and other immune-modifying compounds.

  2010cited by this paper
• Evidence for the Role of Peroxisome Proliferator-Activated Receptor-β/δ in the Development of Spinal Cord Injury

  2010influential reference
• Peroxisome proliferator‐activated receptor δ agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis

  2010cited by this paper
• Efficacy and safety of quinine-artesunate in an HIV-positive patient with severe falciparum malaria.

  2010cited by this paper
• Role of PPAR-δ in the development of zymosan-induced multiple organ failure: an experiment mice study

  2010cited by this paper
• TNF family members and malaria: old observations, new insights and future directions.

  2010cited by this paper
• PPARs: diverse regulators in energy metabolism and metabolic diseases

  2010cited by this paper
• Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

  2009cited by this paper
• Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali

  2009cited by this paper
• Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

  2009influential reference
• PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance

  2009cited by this paper
• Peroxisome Proliferator-Activated Receptor-&ggr; Agonists Promote Differentiation and Antioxidant Defenses of Oligodendrocyte Progenitor Cells

  2009cited by this paper
• Synthesis of Lipoxin A4 by 5-Lipoxygenase Mediates PPARγ-Dependent, Neuroprotective Effects of Rosiglitazone in Experimental Stroke

  2009cited by this paper
• Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages.

  2009cited by this paper
• Dysregulation of coagulation in cerebral malaria

  2009influential reference
• Seventy-five years of Resochin® in the fight against malaria

  2009influential reference
• Peroxisome Proliferator-Activated Receptor &dgr; Regulates Extracellular Matrix and Apoptosis of Vascular Smooth Muscle Cells Through the Activation of Transforming Growth Factor-β1/Smad3

  2009cited by this paper
• Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.

  2009cited by this paper
• Role of PPARs in Radiation-Induced Brain Injury

  2009influential reference
• IP-10-Mediated T Cell Homing Promotes Cerebral Inflammation over Splenic Immunity to Malaria Infection

  2009cited by this paper
• The role of herbal PPAR modulators in the treatment of cardiometabolic syndrome.

  2009cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

  2009cited by this paper
• Modulation of transcription by the peroxisome proliferator-activated receptor δ–binding RNA aptamer in colon cancer cells

  2009cited by this paper
• Headache and malaria: a brief review.

  2009cited by this paper
• Activation of PPARβ/δ inhibits leukocyte recruitment, cell adhesion molecule expression, and chemokine release

  2009influential reference
• [Cerebral malaria].

  2009cited by this paper
• The Role of PPARs in MDR - a lesson from embryonic development.

  2009cited by this paper
• PPAR and Pain.

  2009cited by this paper
• PPARδ-mediated macrophage activation: a matter of fat

  2009cited by this paper
• A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease.

  2009cited by this paper
• Rosiglitazone Alone Or in Combination with Tissue Plasminogen Activator Improves Ischemic Brain Injury in an Embolic Model in Rats

  2009influential reference
• Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.

  2009cited by this paper
• PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice.

  2009cited by this paper
• Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium.

  2009cited by this paper
• Triclosan inhibit the growth of the late liver‐stage of Plasmodium

  2009cited by this paper
• Erythrocytic Casein Kinase II Regulates Cytoadherence of Plasmodium falciparum-infected Red Blood Cells

  2009cited by this paper
• PPARdelta is a type 1 IFN target gene and inhibits apoptosis in T cells.

  2008cited by this paper
• Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742

  2008cited by this paper
• High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

  2008cited by this paper
• PPARδ-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

  2008cited by this paper
• Genetic characterization and evolutionary inference of TNF-alpha through computational analysis.

  2008cited by this paper
• Peroxisome Proliferator-Activated Receptor β/δ Activation Improves Angiotensin II-Induced Cardiac Hypertrophy in Vitro

  2008influential reference
• Chorea in a 29-year-old Nigerian following antimalarial treatment with artesunate.

  2008cited by this paper
• Cortical Expression of Peroxisome Proliferator-activated Receptor-α after Human Brain Contusion

  2008cited by this paper
• CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN‐γ‐induced chemokines

  2008cited by this paper
• PPAR-γ, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

  2008cited by this paper
• Review: PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury

  2008cited by this paper
• Evidence of artemisinin-resistant malaria in western Cambodia.

  2008cited by this paper
• Both Functional LTβ Receptor and TNF Receptor 2 Are Required for the Development of Experimental Cerebral Malaria

  2008cited by this paper
• Peroxisome proliferator-activated receptor gamma agonist, rosiglitazone, suppresses CD40 expression and attenuates inflammatory responses after lithium pilocarpine-induced status epilepticus in rats

  2008influential reference
• Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

  2008cited by this paper
• Activation of Peroxisome Proliferator–Activated Receptor β/δ Inhibits Lipopolysaccharide-Induced Cytokine Production in Adipocytes by Lowering Nuclear Factor-κB Activity via Extracellular Signal–Related Kinase 1/2

  2008cited by this paper
• Ventricular fibrillation in a 5-year-old child on therapeutic dose of quinine dihydrochloride infusion for acute malaria.

  2008cited by this paper
• Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells

  2008cited by this paper
• Ligand Activation of Peroxisome Proliferator–Activated Receptor b / d (PPAR b / d ) Attenuates Carbon Tetrachloride Hepatotoxicity by Downregulating Proinflammatory Gene Expression

  2008cited by this paper
• Regulation of Glial Cell Functions by PPAR-γ Natural and Synthetic Agonists

  2008cited by this paper
• Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8α+ dendritic cells

  2008influential reference
• Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria

  2008cited by this paper
• The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria—inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase

  2008cited by this paper
• Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.

  2008cited by this paper
• Control of pathogenic CD8+ T cell migration to the brain by IFN‐γ during experimental cerebral malaria

  2008cited by this paper
• Activation of peroxisome proliferator-activated receptor-γ by curcumin blocks the signaling pathways for PDGF and EGF in hepatic stellate cells

  2008cited by this paper
• Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.

  2008cited by this paper
• PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis

  2008cited by this paper
• Peroxisome Proliferator-Activated Receptor β/δ in the Brain: Facts and Hypothesis

  2008cited by this paper
• Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

  2008cited by this paper
• World Malaria Report, 2008.

  2008cited by this paper
• Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: Role of IL-1beta and 15-HETE

  2008cited by this paper
• Ventricular fibrillation in a 5-year-old child on therapeutic dose of quinine dihydrochloride infusion for acute malaria.

  2008cited by this paper
• [Quinine-induced renal bilateral cortical necrosis].

  2008cited by this paper
• A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria.

  2007cited by this paper
• CD44, a signal receptor for the inhibition of the cytoadhesion of CD36-binding Plasmodium falciparum-infected erythrocytes by CSA-binding infected erythrocytes.

  2007cited by this paper
• Immunomodulatory therapy associated to anti-parasite drugs as a way to prevent severe forms of malaria.

  2007cited by this paper
• Brain endothelial PPARgamma controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro.

  2007cited by this paper
• An edible vaccine for malaria using transgenic tomatoes of varying sizes, shapes and colors to carry different antigens.

  2007cited by this paper
• Neurological Recovery-Promoting, Anti-Inflammatory, and Anti-Oxidative Effects Afforded by Fenofibrate, a PPAR Alpha Agonist, in Traumatic Brain Injury

  2007cited by this paper
• Cardiotoxicity of antimalarial drugs.

  2007cited by this paper
• Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.

  2007cited by this paper
• Neural Cell Adhesion Molecule, a New Cytoadhesion Receptor for Plasmodium falciparum-Infected Erythrocytes Capable of Aggregation

  2007cited by this paper
• Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.

  2007cited by this paper
• Activation of PPAR&bgr;/&dgr; Induces Endothelial Cell Proliferation and Angiogenesis

  2007cited by this paper
• Brain endothelial PPARγ controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro

  2007cited by this paper
• Malaria: severe, life-threatening.

  2007cited by this paper

• Murine skeletal muscle satellite cells isolation and preliminary study on regulation in immune microenvironment during nurse cells formation of Trichinella spiralis infection.

  2024cites this paper
• Emerging avenues for the management of cerebral malaria.

  2022cites this paper
• Conjugated linoleic acid enhances intestinal mucosal innate immunity against parasite Giardia lamblia in a murine model

  2018cites this paper
• PPARα Agonist Suppresses Inflammation after Corneal Alkali Burn by Suppressing Proinflammatory Cytokines, MCP-1, and Nuclear Translocation of NF-κB

  2018cites this paper
• Differences in the modulation of reactive species, lipid bodies, cyclooxygenase-2, 5-lipoxygenase and PPAR-γ in cerebral malaria-susceptible and resistant mice.

  2017cites this paper
• The molecular mechanisms of action of PPAR-γ agonists in the treatment of corneal alkali burns (Review)

  2016cites this paper
• Multiscale modelling of relationships between protein classes and drug behavior across all diseases using the CANDO platform.

  2015cites this paper
• Enabling systems-level analyses of the host response to infectious diseases in bovine and other mammalian species

  2014cites this paper
• Chalcone and curcumin derivatives: a way ahead for malarial treatment.

  2013cites this paper
• Pathway-GPS and SIGORA: identifying relevant pathways based on the over-representation of their gene-pair signatures

  2013cites this paper
• Current Advances in Cerebral Malaria Associated Encephalopathy

  2012cites this paper
• An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria

  2012cites this paper
• Heme Mediated STAT3 Activation in Severe Malaria

  2012cites this paper
• Cerebral malaria: we have come a long way.

  2012cites this paper
• Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria

  2011cites this paper